Results 91 to 100 of about 12,282,811 (238)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Managing Reference “Pseudoserials” [PDF]

The Serials Librarian, 1993
Christopher W. Nolan, Sharon Scott
openaire   +1 more source

Outstanding Business Reference Sources: The 2005 Selection of Recent Titles

, 2006
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

Gestion optimisée des intrants pour une réponse efficace en contexte de pandémie au Cameroun

Journal of Public Health in Africa
Optimised supplies management for an efficient response in a context of a pandemic in Cameroon. Background: Response strategy against COVID-19 relies on adequate materials and consumables supply.
Joseph Fokam, Cyrille Alain Abega Abega, Ezechiel Ngoufack Jagni Semengue, Aissatou Abba, Désiré Takou, Grace Angong Beloumou, Sandrine Claire Djupsa Ndjeyep, Alex Durand Nka, Davy-Hyacinthe Anguechia Gouissi, Derrick Ayuk Ngwese Tambe, Chenwi Collins, Aude Christelle Ka’e, Michel Carlos Tommo Tchouaket, Rachel Audrey Nayang Mundo, Aurelie Minelle Kengni Ngueko, Naomi-Karell Etame, Larissa Gaelle F. Moko, Evariste Molimbou, Willy Leroi Togna Pabo, Pamela Patricia Tueguem, Nadine Fainguem, Lionele F. Mba, Laeticia Grace Yatchou, Nafissatou Ibnou, Thaddée Bienvenu Onana, Yap Boum II, Alain Georges Etoundi Mballa, Alexis Ndjolo   +27 more
doaj   +1 more source

Reference Notes (February 2003)

, 2003
Table of Contents includes: Reference Services: Virtual, Digital, and In-Library- A New Model for Effective Delivery, Part I; ELM Update; Digital Reference Update; Time Management Tips From Soaring to Excellence 2003 Library Teleconference; Information ...
Minitex Reference Outreach & Instruction
core  

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Outstanding Business Reference Sources: The 2007 Selection of Recent Titles

, 2008
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Outstanding Business Reference Sources: The 2006 Selection of Recent Titles

, 2007
A selection of business reference sources for ...
BRASS Business Reference Sources Committee
core